Prospects for fluorescence molecular in vivo liquid biopsy of circulating tumor cells

Joshua Pace; Madduri Srinivasarao; Shivakrishna Kallepu; Riley Whalen; Heather Theison; Grace Hubbell; Lei G. Wang; Melissa H. Wong; Summer L. Gibbs; Philip S. Low; Mark Niedre

doi:10.1117/12.3002790

13 March 2024 Prospects for fluorescence molecular in vivo liquid biopsy of circulating tumor cells

Joshua Pace, Madduri Srinivasarao, Shivakrishna Kallepu, Riley Whalen, Heather Theison, Grace Hubbell, Lei G. Wang, Melissa H. Wong, Summer L. Gibbs, Philip S. Low, Mark Niedre

Author Affiliations +

Proceedings Volume PC12825, Molecular-Guided Surgery: Molecules, Devices, and Applications X; PC128250A (2024) https://doi.org/10.1117/12.3002790
Event: SPIE BiOS, 2024, San Francisco, California, United States

Abstract

We discuss our work in development of ‘Diffuse in vivo Flow Cytometry’ (DiFC) for non-invasive fluorescence enumeration of circulating tumor cells (CTCs) and describe recent progress towards human translation of DiFC. DiFC is an emerging technique wherein highly-scattered light is used to non-invasively sample blood flowing in large deep-seated blood vessels and detect fluorescently-labeled cells. The key advantages are that it allows continuous sampling of large circulating blood volumes and enumeration of rare cells over time. We discuss progress in development an application of near-infrared fluorescent molecular contrast agents for sensitive and specific labeling of CTCs directly in vivo. Candidate contrast agents include a folate receptor-targeted probe (OTL38, Cytalux), as well as new, purpose-designed pan-epithelial CTC-specific probes. We also discuss relevant tissue optics and instrumentation considerations for potential future human translation. Ultimately, DiFC could represent a new method for continuously enumerating CTCs without drawing blood samples that may enable early detection of cancer metastasis or monitoring of response to cancer therapies.

Conference Presentation

Citation Download Citation

Joshua Pace, Madduri Srinivasarao, Shivakrishna Kallepu, Riley Whalen, Heather Theison, Grace Hubbell, Lei G. Wang, Melissa H. Wong, Summer L. Gibbs, Philip S. Low, and Mark Niedre "Prospects for fluorescence molecular in vivo liquid biopsy of circulating tumor cells", Proc. SPIE PC12825, Molecular-Guided Surgery: Molecules, Devices, and Applications X, PC128250A (13 March 2024); https://doi.org/10.1117/12.3002790

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
PRESENTATION

WATCH
PRESENTATION SAVE TO MY LIBRARY

GET CITATION

KEYWORDS

In vivo imaging

Cancer detection

Fluorescence

Biopsy

Contrast agents

Liquids

Tumors

Show All Keywords

Keywords/Phrases

Search In:

Publication Years